Targeted therapies for ErbB and related receptors (EGFR, HER2); Inhibitors for TNF family of receptors: TNFR, RANK etc.; Protein engineering for antibody-like proteins; Biomarkers to facilitate treatment for breast cancer and Melanoma
Investigator: Hongtao Zhang, PhD